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A utologous saphenous vein grafts continue to be tra-ditionally used conduits for coronary revasculariza-
tion. However, 25% to 31% of grafts are totally occlud-
ed or stenotic at 5 years, and 48% to 66% are totally
occluded at more than 10 years after coronary artery
bypass grafting (CABG).1,2 On the other hand, arterial
grafts, such as an internal thoracic artery, are superior to
the saphenous vein grafts in late patency.1 Nonetheless,
10% to 23% of grafts still show evidence of occlusion
or stenosis at 5 years.3
The success of CABG depends on many factors,
including technical aspects. Surgical preparation, such
Objective: The proliferation of vascular smooth muscle cells surrounding a
suture line is an important factor in the development of anastomotic stricture
that is frequently seen after coronary artery bypass grafting. The aim of this
study was to investigate the time course of intimal thickening and to exam-
ine the expression of the molecular marker of smooth muscle cell activation
surrounding the suture line.
Methods: Longitudinal aortotomy was performed in the abdominal aorta of
rats. The rats were put to death 1, 2, 4, and 8 weeks after aortotomy, and the
percentage of the lumen occluded by intimal thickening was calculated. All
tissues were stained with antibodies against basic transcription element–
binding protein 2, human cyclin-dependent kinase (cdk4), and Sp1 for
immunohistochemistry. Basic transcription element–binding protein 2 is a
transcription factor that is involved in phenotypic modulation of vascular
smooth muscle cells. Cdk4 represents a marker for G1 phase of the cell cycle.
Sp1 is a transcription factor known to be expressed in a variety of tissues.
Basic transcription element–binding protein 2 messenger RNA expression
was confirmed by means of reverse transcriptase–polymerase chain reaction.
Results: We noted significant thickening of the intimal layer 1 week after
aortotomy. Immunohistochemistry demonstrated that smooth muscle cells in
the neointima were strongly positive for basic transcription element–binding
protein 2 and human cyclin-dependent kinase 4, which peaked 2 weeks after
aortotomy. Basic transcription element–binding protein 2 expression was
closely associated with human cyclin-dependent kinase 4 expression in the
neointima, although Sp1 was not. Basic transcription element–binding pro-
tein 2 messenger RNA levels were significantly up-regulated early after aor-
totomy.
Conclusion: The experimental rat aortotomy model is useful to investigate
the proliferation of vascular smooth muscle cells around the suture line.
Moreover, our results suggest the possible role of basic transcription ele-
ment–binding protein 2 in the development of vascular anastomotic stric-
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INDUCIBLE EXPRESSION OF BASIC TRANSCRIPTION ELEMENT–BINDING PROTEIN 2 IN 
PROLIFERATING SMOOTH MUSCLE CELLS AT THE VASCULAR ANASTOMOTIC STRICTURE
as direct mechanical trauma or luminal distention,
leads to medial and endothelial damage.4 Occlusion or
stenosis may result from early vascular wall ischemia
as a result of poor early perfusion of the vasa vasorum.5
The vascular geometry has been described as a risk fac-
tor in atherogenesis.6 Moreover, intimal thickening
around a suture line, although technically nonpre-
ventable, is also an important factor in the development
of a vascular anastomotic stricture after CABG. This
condition has been shown to occur preferentially at the
heel and toe of the junction and at the suture line in the
anastomosis configuration early after graft implanta-
tion, gradually increasing particularly at the toe portion
of anastomosis.7-9 Later, the intimal thickening increas-
es excessively, and severe luminal stenosis develops.9
These phenomena may be caused by the invasion and
proliferation of smooth muscle cells (SMCs), fibro-
blasts, and matrix materials derived from the cut end of
the host artery.10-12
Although a number of genes are differentially
expressed between proliferating and quiescent vascular
SMCs, the transcription factors that play a role in this
process remain largely unknown. We have recently
demonstrated that basic transcription element–binding
protein 2 (BTEB2), guanine cytosine (GC) box–bind-
ing zinc finger protein, is a transcription factor regulat-
ing the SMemb gene, which is also known as the non-
muscle myosin heavy chain-B isoform gene.13 Our
recent experiments have demonstrated that BTEB2
expression is down-regulated during aortic develop-
ment and is reinduced after balloon injury.13,14 Ex-
pression of transcription factors, such as BTEB2, in
proliferating vascular SMCs at the anastomosis
remains to be investigated.
The aim of this study was to investigate the time
course of intimal thickening and to examine the expres-
sion of the molecular marker of SMC activation sur-
rounding a suture line by using a simple animal model
as a substitute for a vascular anastomotic stricture.
Material and methods
Antibodies. We developed a monoclonal antibody against
human BTEB2 by using an oligopeptide.13 Monoclonal anti-
body against human α-smooth muscle actin (SMα-actin) was
purchased from DAKO A/S. Two polyclonal antibodies
against human cyclin-dependent kinase 4 (cdk4) and Sp1
were purchased from Santa Cruz Biotechnology, Inc. These
antibodies were used for immunohistochemistry.
Animals. Adult male Wistar rats weighing 150 to 200 g
were used in this study. They were housed under convention-
al conditions and fed a standard diet and water. Rats were
purchased from Charles River Co. The protocol of this inves-
tigation was approved by the Institutional Committee for the
Care and Use of Laboratory Animals in Gunma University
School of Medicine.
Rat aortotomy model. Rats were anesthetized with sodium
pentobarbital (30 mg/kg body weight) administered by means
of intraperitoneal injection. The abdominal aorta was exposed
from below the renal arteries to just above the aortic bifurcation
through a midline incision in the abdomen. The abdominal
aorta was clamped, and a longitudinal aortotomy (5 mm in
length) was made. The wound was immediately closed by using
a continuous suture of 9-0 monofilament nylon without disturb-
ing the intima. After confirmation of patency and the absence of
bleeding, the abdominal wall was closed in layers.
Euthanasia. In the injured groups rats were put to death 1,
2, 4, and 8 weeks after aortotomy. In the control group rats
were put to death without aortotomy. The aortas were perfu-
sion fixed in situ with 10% (wt/vol) buffered formalin (pH
7.4) at 100 mm Hg after infusion of saline solution contain-
ing heparin (20 U/mL, Shimizu Pharmaceutical Co) adminis-
tered through a cannula placed in the left ventricle. They were
then removed and placed in 10% buffered formalin for further
fixation. The central parts of the excised vessel were embed-
ded in paraffin, and 3-µm cross sections were prepared.
Evaluation of intimal thickening. Serial sections from tis-
sue were stained with hematoxylin and eosin and elastica to
indicate the intima and internal elastic lumina. The intimal
and medial cross-sectional areas were calculated blindly by
using an imaging analysis system. The ratio of intimal to
medial cross-sectional areas (I/M ratio) was also determined
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Fig 1. The I/M ratio on the suture line. Significant thickening
of the intimal layer was seen 1 week after aortotomy, and it
peaked at 2 weeks. These values were not statistically differ-
ent within the injured groups but significantly (P < .01)
increased in the injured groups compared with the control
animals. Values were expressed as mean ± SD.
blindly by using an imaging analysis system (Adobe Photo-
shop 5.0J, NIH Image 1.61/ppc).
Immunohistochemical analysis. All tissues were stained
with antibodies against BTEB2, SMα-actin, cdk4, or Sp1.
BTEB2 is a transcription factor that is involved in phenotyp-
ic modulation of vascular SMCs.13,14 SMα-actin is an iso-
form of smooth muscle actin and represents a marker for
myoblasts and SMCs.15,16 Cdk4 was used as a marker for
DNA synthesis of vascular SMCs in this study. The synthesis
of cyclin D1 and its assembly with cdk4 to form an active
complex is a rate-limiting step in progression through the G1
phase of the cell cycle.17 Sp1 is known to be expressed in a
variety of tissues18 and is potentially a crucial transcription
factor for the expression of many genes.19 Immunoenzymatic
staining was carried out by using a Vectastatin Elite ABC Kit
(Vector Laboratories). Sections were preincubated in
methanol containing 0.3% hydrogen peroxide for 30 minutes
and blocked with Protein Blocking Serum Free (Dako Corp)
solution for 15 minutes to reduce nonspecific reactions.
Antibodies against BTEB2 (1:4000), SMα-actin (1:50), cdk4
(1:100), and Sp1(1:100) were applied and incubated for 30
minutes at room temperature. Sections were incubated with
biotinyl-labeled immunoglobulins for 30 minutes and then
incubated with horseradish peroxidase–labeled streptavidin
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Fig 2. Photomicrographs of the immunohistochemistry of developing aorta (original magnification ×200). In con-
trol animals no evident staining of BTEB2, cdk4, or Sp1 was detected in any layer, although SMα-actin staining
was observed in the medial layer of aorta. After aortic injury, neointimal cells were extensively stained with anti-
SMα-actin antibody, indicating proliferation of SMCs. SMα-actin staining was observed in both the intimal and
the medial layer of the aorta and even in the adventitia 1, 2, 4, and 8 weeks after aortotomy. We found BTEB2-
and cdk4-positive SMCs in the neointima 1 week after aortotomy. These levels peaked at 2 weeks, and SMCs
were strongly positive for BTEB2 and cdk4 in the neointima. Only a few cells beneath the internal elastic lami-
na were positive for BTEB2 and cdk4 in the media. BTEB2-positive cells were also observed in the adventitia
around the suture, where SMα-actin-positive cells were present. Sp1 was expressed in the neointima but not nec-
essarily localized to the neointimal SMCs. Sp1-positive cells existed during the entire duration of injury.
solution for 30 minutes. Peroxidase activity was revealed by
3,3´-diaminobenzidine tetrahydrochloride (0.2 mg/mL,
Sigma Chemical Co) with hydrogen peroxide (0.015%). The
sections were counterstained with methyl green, dehydrated,
and mounted.
Percentage of BTEB2-labeled cells. The percentage of
BTEB2-labeled cells in neointima was evaluated at each time
point (labeled cells/total cells × 100). Cells were counted as
positive for BTEB2 when distinctly stained for immunohisto-
chemistry.
Reverse transcription–polymerase chain reaction
Southern blot analysis. BTEB2 transcripts were evaluated
by using reverse transcription–polymerase chain reaction
(RT-PCR) Southern blot analysis for normal control aortas
and aortas at 1 and 2 weeks after aortotomy. Aortas were har-
vested and immediately fixed with liquid nitrogen, and total
RNA was prepared by using the acid guanidinium thio-
cyanate-phenol-chloroform method (ISOGEN, Nippon
Gene). Aliquots of RNA derived from aortas were amplified
simultaneously by PCR (35 cycles) with rat BTEB2 primers14
or reduced glyceraldehyde-phosphate dehydrogenase
(GAPDH) primers. PCR products were subjected to elec-
trophoresis through 2% agarose gels stained with ethidium
bromide. Fragments were blotted to a nylon membrane
(Hybond N+, Amersham), and the specificity of gene amplifi-
cations was confirmed by means of Southern blot analysis.
Hybridization was performed with isotope-labeled rat
BTEB2 complementary (c)DNAs14 and GAPDH cDNAs
(Ready-To-Go DNA labeling Kit [-dCTP], Pharmacia
Biotech). The radioactivity of corresponding bands was
quantified by using a FUJIX BIO-Imaging Analyzer BAS
2000 (Fuji Photo Film). BTEB2 messenger (m)RNA levels
were normalized to GAPDH mRNA levels by calculating the
ratio of BTEB2 mRNA/GAPDH mRNA radioactivity for
each sample.
Statistical analysis. All values were expressed as means ±
SD. Statistical comparisons were performed with a commer-
cially available statistical package for the Macintosh person-
al computer (STAT VIEW-J5.0, Abacus Concepts). Data were
analyzed with analysis of variance for multiple comparisons.
If a significant P value was present, the Bonferroni correction
was used to identify specific intergroup differences.
Results
Evaluation of intimal thickening. Rats were ran-
domly separated into 4 injured groups after aortotomy
(n = 15 in each group). Six rats of the injured group
were excluded from observation because of retroperi-
toneal abscess (n = 3) and unknown cause of death
(n = 3). The control rats were killed without aortotomy
(n = 15).
We found significant thickening of the intimal layer
1 week after aortotomy (Fig 1). Values of I/M ratio
were 9.8% ± 6.5% (n = 13), 14.5% ± 11.8% (n = 14),
8.4% ± 5.3% (n = 15), and 9.2% ± 7.4% (n = 12) at 1,
2, 4, and 8 weeks after aortotomy, respectively, in the
injured groups and 0.5% ± 0.3% (n = 15) in the control
group. These values were not statistically different
throughout the injured groups but increased signifi-
cantly in the injured groups compared with the control
animals (P = .003, P = .0001, P = .007, and P = .005,
respectively).
Immunohistochemical analysis. Immunohisto-
chemistry was performed by use of antibodies to
BTEB2, SMα-actin cdk4, and Sp1 (Fig 2). Our results
demonstrated that SMCs in the neointima were strong-
ly positive for BTEB2 and cdk4, which peaked 2 weeks
after aortotomy. BTEB2 expression was closely associ-
ated with cdk4 expression in the neointima, although
Sp1 was not.
Percentage of BTEB2-labeled cells. The percentage
of BTEB2-labeled cells in neointima was evaluated for
each time point (Fig 3). The percentage peaked at 2
weeks after aortotomy and gradually declined there-
after. Values were 31.7% ± 13.2% (n = 13), 34.6% ±
5.0% (n = 14), 32.9% ± 6.4% (n = 15), and 20.0% ±
5.0% (n = 12) at 1, 2, 4, and 8 weeks after aortotomy,
respectively. These values decreased significantly at 8
weeks after injury compared with 2 weeks (P = .0002)
or 4 weeks (P = .003) after injury.
RT-PCR Southern blot analysis. The rats were ran-
domly separated into two injured groups after aortoto-
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Fig 3. The percentage of BTEB2-labeled cells. The percent-
age of BTEB2-labeled cells in neointima peaked at 2 weeks
and gradually declined thereafter. These values were signifi-
cantly (P < .01) decreased at 8 weeks compared with 2 or 4
weeks. Values were expressed as mean ± SD.
my (n = 3 in each group). The control rats were killed
without aortotomy (n = 3). BTEB2 mRNA expression
early after aortotomy was confirmed by means of RT-
PCR and Southern blot analyses (Fig 4, A). BTEB2
mRNA levels were evaluated for normal control aortas
and aortas at 1 week and 2 weeks after aortotomy.
Relative BTEB2 mRNA levels were quantified, and
their values were 21.5% ± 5.0% for the control rats and
61.9% ± 23.8% and 63.9% ± 23.3% at 1 and 2 weeks
after aortotomy, respectively. These values were signif-
icantly higher at 1 week (P = .04) or 2 weeks (P = .03)
compared with the control rats (Fig 4, B).
Discussion
The proliferation of vascular SMCs surrounding a
suture line is an important factor in the development of a
vascular anastomotic stricture that is frequently noted
after CABG. We have recently identified BTEB2 as a
transcription factor regulating the expression of the
SMemb gene, which is involved in the phenotypic mod-
ulation of vascular SMCs. In the present study we inves-
tigated the expression of BTEB2 by using an aortotomy
model, which could be substituted for a vascular anasto-
motic stricture. BTEB2 expression increased in the
neointimal layer accompanying the development of inti-
mal thickening, and BTEB2 mRNA expression was also
confirmed by means of RT-PCR. Moreover, BTEB2
expression was closely associated with cdk4 expression
in the neointima, although Sp1 expression was not. Thus
our results suggest that BTEB2 plays a potential role in
the development of vascular anastomotic strictures.
We used the aortotomy model because intimal thick-
ening is regularly observed after this procedure. In con-
trast to previous experimental models of vascular anas-
tomotic stricture in which an end-to-end or an
end-to-side anastomosis was performed,9,20,21 our
model readily allowed us to measure the intimal thick-
ening at the suture line. The proliferation of vascular
SMCs around the suture line was remarkable in the
sense that the I/M ratio increased as rapidly as is seen
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Fig 4. BTEB2 mRNA levels early after aortotomy by RT-PCR and Southern blot analyses. A, Autoradiograms of
Southern blot analysis of PCR products. BTEB2 and GAPDH mRNAs from normal control aortas and aortas 1
and 2 weeks after aortotomy were amplified by RT-PCR. B, Summary of the quantitative changes in relative
BTEB2 mRNA expression levels. These values were significantly (P < .05) higher at 1 or 2 weeks compared with
the control animals. Values were expressed as mean ± SD.
A
B
after balloon injury.22,23 The time course of intimal
thickening after aortotomy was comparable with that
reported in balloon injury models.22,23
Identification of transcription factors that are specifi-
cally activated in response to vascular injury is important
for investigation of the molecular mechanisms responsi-
ble for development of anastomotic stenosis after CABG.
The GC-rich sequence, the so-called GC box, is an
important transcriptional regulatory element in the pro-
motions of many mammalian genes.24,25 As a factor bind-
ing to the GC box, Sp1 was first identified and was shown
to be an important component for the basal transcription-
al machinery.19,26 Recently, several members of Krüppel-
like transcription factors, including BTEB2, erythroid
Krüppel-like factor (EKLF), and lung Krüppel-like factor
(LKLF), have been cloned and characterized as GC
box–binding factors.27,28 These proteins and Sp1 com-
monly contain 3 contiguous Cys2-His2 zinc finger motifs
at their C-terminal region as a DNA-binding domain.29
We have recently identified a cDNA clone encoding GC
box–binding zinc finger protein BTEB2 as a transcription
factor regulating the SMemb gene, also known as the
nonmuscle myosin heavy chain-B isoform gene.13 Our
initial in vitro experiments have indicated that BTEB2 is
preferentially expressed in proliferating vascular SMCs
and that BTEB2 mRNA levels are rapidly increased on
mitogenic stimulation.13 We have also demonstrated pos-
itive staining for BTEB2 in the neointimal layer of bal-
loon-injured aorta.14 Therefore we have postulated that
BTEB2 may play a regulatory role in activated vascular
SMCs. Likewise, the present study suggests that BTEB2
could promote the proliferation of vascular SMCs around
the suture line formed in an aortotomy model, which
could substitute for an anastomotic stricture.
In summary, a simple experimental rat aortotomy
model was proved to be useful in the examination of
intimal thickening surrounding the suture line. This
model may be suitable in studies of acute reaction
rather than chronic change of the vascular anastomotic
stricture. Moreover, our results suggest that the induced
expression of BTEB2 may play an important role in
stimulating SMC proliferation and a possible role in
vascular anastomotic strictures. Further studies should
be directed toward elucidating the function of BTEB2
in vascular anastomotic strictures by suppressing its
expression through an antisense strategy.
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